A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma
Abstract The lack of an appropriate preclinical model of metabolic dysfunction-associated steatotic liver disease (MASLD) that recapitulates the whole disease spectrum impedes exploration of disease pathophysiology and the development of effective treatment strategies. Here, we develop a mouse model...
Saved in:
| Main Authors: | Byung-Kwan Jeong, Won-Il Choi, Wonsuk Choi, Jieun Moon, Won Hee Lee, Chan Choi, In Young Choi, Sang-Hyun Lee, Jung Kuk Kim, Young Seok Ju, Pilhan Kim, Young-Ah Moon, Jun Yong Park, Hail Kim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-08-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-024-50660-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serotonin Regulates Lipogenesis and Endoplasmic Reticulum Stress in Alcoholic Liver Disease
by: Inseon Hwang, et al.
Published: (2025-07-01) -
Synergistic effects of L-arginine and argininosuccinate synthetase 1 in inducing apoptosis in hepatocellular carcinoma
by: Jin Sun Kim, et al.
Published: (2025-03-01) -
Reply to: “Comment on “Lower incidence of hepatocellular carcinoma with tenofovir alafenamide in chronic hepatitis B: Evidence from a large-scale cohort””
by: Jisoo Lee, et al.
Published: (2025-05-01) -
Phocaeicola dorei ameliorates progression of steatotic liver disease by regulating bile acid, lipid, inflammation and proliferation
by: Jieun Choi, et al.
Published: (2025-12-01) -
Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab
by: Jaejun Lee, et al.
Published: (2024-12-01)